QT IMAGING HOLDINGS, INC. Induced Conversion of Convertible Debt Expense
QT IMAGING HOLDINGS, INC. (QTI) reported Induced Conversion of Convertible Debt Expense of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InducedConversionOfConvertibleDebtExpense · last filed 2026-08-12
- QT IMAGING HOLDINGS, INC. induced conversion of convertible debt expense for the quarter ending 2026-06-30 was $0.00.
- QT IMAGING HOLDINGS, INC. induced conversion of convertible debt expense for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- QT IMAGING HOLDINGS, INC. induced conversion of convertible debt expense for the quarter ending 2025-06-30 was $0.00.
- QT IMAGING HOLDINGS, INC. induced conversion of convertible debt expense for the quarter ending 2025-03-31 was $6.64M.
- QT IMAGING HOLDINGS, INC. induced conversion of convertible debt expense for fiscal 2025 was $6.64M.
- QT IMAGING HOLDINGS, INC. induced conversion of convertible debt expense for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- QT IMAGING HOLDINGS, INC. induced conversion of convertible debt expense for fiscal 2023 was $168.36K.
| Period end | Induced Conversion of Convertible Debt Expense 3 month | Induced Conversion of Convertible Debt Expense 6 month | Induced Conversion of Convertible Debt Expense 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | ||
| 2025-12-31 | $6.64M 10-K · filed 2026-03-25 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-12 | $6.64M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $6.64M 10-Q · filed 2026-05-13 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-25 | ||
| 2023-12-31 | $168.36K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |